Foundation Medicine Inc (Foundation Medicine) is a molecular information products provider. The company provides molecular information and cancer research programs. It offers clinical products such as FoundationOne for solid tumors and FoundationOne Heme for blood-based cancers, or hematologic malignancies, including leukemia, lymphoma, and sarcomas; FoundationACT, a blood-based circulating tumor DNA (ctDNA) assay for solid tumor; and FoundationOne CDx, a diagnostic assay for solid tumors. It also provides additional materials, services, and real-time data through its technology products. The company partners with biotech and pharmaceutical companies to develop targeted cancer therapies and active clinical trials. Foundation Medicine is headquartered in Cambridge, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Note: Some sections may be missing if data is unavailable for the company
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Foundation Medicine Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Foundation Medicine Inc Company Overview
- Foundation Medicine Inc Company Snapshot
- Foundation Medicine Inc Pipeline Products and Ongoing Clinical Trials Overview
- Foundation Medicine Inc - Pipeline Analysis Overview
- Foundation Medicine Inc - Key Facts
- Foundation Medicine Inc - Major Products and Services
- Foundation Medicine Inc Pipeline Products by Development Stage
- Foundation Medicine Inc Ongoing Clinical Trials by Trial Status
- Foundation Medicine Inc Pipeline Products Overview
- bTMB Assay
- bTMB Assay Product Overview
- bTMB Assay Clinical Trial
- Companion Diagnostic Test - AG-120
- Companion Diagnostic Test - AG-120 Product Overview
- Companion Diagnostic Test - AG-221
- Companion Diagnostic Test - AG-221 Product Overview
- Confera Diagnostic Kit
- Confera Diagnostic Kit Product Overview
- ctDNA Monitoring Assay
- ctDNA Monitoring Assay Product Overview
- FoundationOne CDx - Mobocertinib
- FoundationOne CDx - Mobocertinib Product Overview
- FoundationOne CDx - Infigratinib
- FoundationOne CDx - Infigratinib Product Overview
- FoundationOne CDx - Vitrakvi
- FoundationOne CDx - Vitrakvi Product Overview
- FoundationOne Liquid CDx - ALUNBRIG
- FoundationOne Liquid CDx - ALUNBRIG Product Overview
- FoundationOne Liquid CDx - Mobocertinib
- FoundationOne Liquid CDx - Mobocertinib Product Overview
- Foundation Medicine Inc - Key Competitors
- Foundation Medicine Inc - Key Employees
- Foundation Medicine Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
Recent Developments
Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- UnitedHealth Group Inc
- Quest Diagnostics Inc
- NeoGenomics Inc
- Caris Life Sciences Inc
